Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol. 2006 Aug 10; 24(23):3789-98.
View in:
PubMed
subject areas
Adenocarcinoma
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Squamous Cell
Chemotherapy, Adjuvant
Critical Pathways
DNA-Binding Proteins
Esophageal Neoplasms
Esophagectomy
Esophagogastric Junction
Female
Fluorouracil
Genes, MDR
Genotype
Humans
Male
Methylenetetrahydrofolate Reductase (NADPH2)
Middle Aged
Neoadjuvant Therapy
Odds Ratio
Platinum Compounds
Polymorphism, Single Nucleotide
Predictive Value of Tests
Prognosis
Proportional Hazards Models
Radiotherapy, Adjuvant
Retrospective Studies
Risk Assessment
Stomach Neoplasms
Survival Analysis
Taxoids
Treatment Outcome